We used data from the Surveillance, Epidemiology, and End Results (SEER) Program to calculate breast cancer incidence trends among this target population over the most recent 20 years and stratified our analyses by race and ethnicity, hormone receptor status, tumor stage, and age at diagnosis. The gene discussed is NR4A1; the disease is breast cancer.